4
Changes in Ownership
RESMED INC Filed Acc 0001127602-25-015607
Chief Financial Officer sold 3,644 shares at $244.59 ($891,286)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sandercock Brett Chief Financial Officer | 2025-05-22 | Sale 10b5-1 | −3,644 | $244.59 | $891,286 | 86,283 | D: show line 1 in the form |
| Open-market sales · 3,644 sh · avg $244.59 · $891,286 | |||||||
Loading xslF345X05/form4.xml…